Soft Target Weight: Theory and Simulation of a Novel Haemodialysis Protocol Which Reduces Excessive Ultrafiltration.

Dialytic symptoms Dry weight Haemodialysis Intra-dialytic hypotension Ultrafiltration

Journal

Nephron
ISSN: 2235-3186
Titre abrégé: Nephron
Pays: Switzerland
ID NLM: 0331777

Informations de publication

Date de publication:
2022
Historique:
received: 05 07 2021
accepted: 13 09 2021
pubmed: 17 11 2021
medline: 7 4 2022
entrez: 16 11 2021
Statut: ppublish

Résumé

Excessive ultrafiltration is associated with intra-dialytic symptoms, loss of residual function, and mortality in haemodialysis patients. A major contributor to excessive ultrafiltration is within-individual variation in pre-dialysis weight and the concept of achieving a fixed target weight by the end of each dialysis session. Haemodialysis protocols which allow variable post-dialysis weight have not been proposed. Weight variation was observed in haemodialysis patients and healthy controls to estimate the proportion of pre-dialysis weight variation which could be considered natural variation. These estimates were used to derive a novel protocol for setting ultrafiltration, which was evaluated by mathematical modelling. Amongst 20 haemodialysis patients, mean (SD) pre-dialysis weight was 102.74 (0.94)% of target weight after a 2-day gap and 103.50 (0.94)% after a 3-day gap. Amongst 10 healthy individuals, mean (SD) daily weight was 100.0 (0.71)% of average weight. A 4-component model of pre-dialysis weight was derived using these estimates, in which the best estimate of pre-dialysis excess fluid is the midpoint of excess weight and average fluid gain, and used to propose a novel protocol for ultrafiltration setting. In simulations, the novel protocol reduced ultrafiltration variation by more than half (standard deviation 0.6 vs. 1.3% of target weight, p < 0.001), without increasing the variation in post-dialysis fluid excess. Excessive ultrafiltration rates (over 13 mL/h/kg) were far less frequent using this protocol (2.6% vs. 7.5% of sessions, p = 0.001). Considering natural weight variation allows the development of a novel protocol for ultrafiltration in which target weight does not have to be achieved precisely: it is therefore a soft target. This protocol, which is predicted to substantially reduce excessive ultrafiltration variation, is a zero-cost intervention with the potential to improve symptoms and clinical outcome for haemodialysis patients.

Identifiants

pubmed: 34784606
pii: 000519823
doi: 10.1159/000519823
pmc: PMC8985015
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-166

Informations de copyright

© 2021 The Author(s). Published by S. Karger AG, Basel.

Références

Contemp Clin Trials Commun. 2019 Jul 19;15:100415
pubmed: 31372573
Nephrol Dial Transplant. 2006 Nov;21(11):3231-7
pubmed: 16954178
Int Urol Nephrol. 2012 Apr;44(2):583-91
pubmed: 21688195
Int J Sport Nutr Exerc Metab. 2004 Oct;14(5):532-40
pubmed: 15673099
Semin Dial. 2016 Sep;29(5):410-5
pubmed: 27150124
Kidney Int. 2011 Jan;79(2):250-7
pubmed: 20927040
PLoS One. 2019 Jan 29;14(1):e0211479
pubmed: 30695068
Am J Nephrol. 2016;43(3):173-8
pubmed: 27064739
Obesity (Silver Spring). 2008 Aug;16(8):1826-30
pubmed: 18551108
Hemodial Int. 2014 Apr;18(2):415-22
pubmed: 24467830
Nephrol Dial Transplant. 1996;11 Suppl 2:11-5
pubmed: 8803987
Kidney Int. 2006 Apr;69(7):1222-8
pubmed: 16609686
Hemodial Int. 2000 Jan;4(1):8-14
pubmed: 28455922
Am J Kidney Dis. 2013 Jun;61(6):957-65
pubmed: 23415416
BMC Nephrol. 2017 Apr 26;18(1):138
pubmed: 28441936
Blood Purif. 2017;44(2):89-97
pubmed: 28334722

Auteurs

Damien Ashby (D)

West London Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.

Richard Corbett (R)

West London Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.

Neill Duncan (N)

West London Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH